143 related articles for article (PubMed ID: 24148436)
21. Sensitive multiplex detection of serological liver cancer biomarkers using SERS-active photonic crystal fiber probe.
Dinish US; Balasundaram G; Chang YT; Olivo M
J Biophotonics; 2014 Nov; 7(11-12):956-65. PubMed ID: 23963680
[TBL] [Abstract][Full Text] [Related]
22. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G
Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222
[TBL] [Abstract][Full Text] [Related]
23. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
Beneduce L; Pesce G; Gallotta A; Zampieri F; Biasiolo A; Tono N; Boscato N; Gatta A; Pontisso P; Fassina G
Eur J Clin Invest; 2008 Aug; 38(8):571-7. PubMed ID: 18625005
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP).
Baig JA; Alam JM; Mahmood SR; Baig M; Shaheen R; Sultana I; Waheed A
J Ayub Med Coll Abbottabad; 2009; 21(1):72-5. PubMed ID: 20364746
[TBL] [Abstract][Full Text] [Related]
25. Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma.
Jiang J; Wu C; Shen Y; Xu B; Zheng X; Li X; Xu N
Anticancer Res; 2011 Feb; 31(2):687-91. PubMed ID: 21378357
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis of hepatocellular carcinoma performed by searching for serologic tumor markers].
de Oliveira e Silva A; Roldan-Molina F; dos Santos TE; Santo GC; Miranda MP; Genzini T; Neves LB; D'Albuquerque LA
Arq Gastroenterol; 1990; 27(2):83-94. PubMed ID: 1709803
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Takasaki K; Takenami K; Yamamoto M; Nakano M
Cancer; 2000 Feb; 88(3):544-9. PubMed ID: 10649245
[TBL] [Abstract][Full Text] [Related]
28. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
Lamerz R; Runge M; Stieber P; Meissner E
Anticancer Res; 1999; 19(4A):2489-93. PubMed ID: 10470180
[TBL] [Abstract][Full Text] [Related]
29. Quantification of Cancer Biomarkers in Serum Using Scattering-Based Quantitative Single Particle Intensity Measurement with a Dark-Field Microscope.
Poon CY; Wei L; Xu Y; Chen B; Xiao L; Li HW
Anal Chem; 2016 Sep; 88(17):8849-56. PubMed ID: 27514775
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.
Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H
Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674
[TBL] [Abstract][Full Text] [Related]
31. Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma.
Moriya S; Morimoto M; Numata K; Nozaki A; Shimoyama Y; Kondo M; Nakano M; Maeda S; Tanaka K
Anticancer Res; 2013 Mar; 33(3):997-1001. PubMed ID: 23482772
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
[TBL] [Abstract][Full Text] [Related]
33. Sensitive amperometric immunosensor for alpha-fetoprotein based on carbon nanotube/gold nanoparticle doped chitosan film.
Lin J; He C; Zhang L; Zhang S
Anal Biochem; 2009 Jan; 384(1):130-5. PubMed ID: 18848914
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous determination of alpha-fetoprotein and carcinoembryonic antigen in human serum by time-resolved fluoroimmunoassay.
Matsumoto K; Yuan J; Wang G; Kimura H
Anal Biochem; 1999 Dec; 276(1):81-7. PubMed ID: 10585747
[TBL] [Abstract][Full Text] [Related]
35. [Surveillance of cirrhosis for hepatocellular carcinoma--clinical validation of new serological biomarkers for improved diagnosis].
Teofănescu I; Gologan E; Stefănescu G; Bălan G
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):39-46. PubMed ID: 20509274
[TBL] [Abstract][Full Text] [Related]
36. Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma.
Tanaka Y; Kashiwagi T; Tsutsumi H; Nagasawa M; Toyama T; Ozaki S; Naito M; Ishibashi K; Azuma M
Hepatogastroenterology; 1999; 46(28):2464-8. PubMed ID: 10522021
[TBL] [Abstract][Full Text] [Related]
37. Conductive carbon nanoparticles-based electrochemical immunosensor with enhanced sensitivity for alpha-fetoprotein using irregular-shaped gold nanoparticles-labeled enzyme-linked antibodies as signal improvement.
Tang J; Su B; Tang D; Chen G
Biosens Bioelectron; 2010 Aug; 25(12):2657-62. PubMed ID: 20483583
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
[TBL] [Abstract][Full Text] [Related]
39. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
[No Abstract] [Full Text] [Related]
40. Enzyme-linked immunosorbent assay for alpha-fetoprotein in human serum.
Chui SH; Yow CM; Lam CW; Wan KC; Lewis WH
Med Lab Sci; 1989 Oct; 46(4):305-8. PubMed ID: 2482399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
